AU2832399A - B cell inhibitors - Google Patents
B cell inhibitorsInfo
- Publication number
- AU2832399A AU2832399A AU28323/99A AU2832399A AU2832399A AU 2832399 A AU2832399 A AU 2832399A AU 28323/99 A AU28323/99 A AU 28323/99A AU 2832399 A AU2832399 A AU 2832399A AU 2832399 A AU2832399 A AU 2832399A
- Authority
- AU
- Australia
- Prior art keywords
- cell inhibitors
- inhibitors
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9802842.6A GB9802842D0 (en) | 1998-02-10 | 1998-02-10 | Organic compounds |
GB9802842 | 1998-02-10 | ||
GB9810688 | 1998-05-19 | ||
GBGB9810688.3A GB9810688D0 (en) | 1998-05-19 | 1998-05-19 | Organic compounds |
GB9826553 | 1998-12-02 | ||
GBGB9826553.1A GB9826553D0 (en) | 1998-12-02 | 1998-12-02 | Organic compounds |
PCT/EP1999/000817 WO1999041239A1 (en) | 1998-02-10 | 1999-02-08 | B cell inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2832399A true AU2832399A (en) | 1999-08-30 |
Family
ID=27269204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28323/99A Abandoned AU2832399A (en) | 1998-02-10 | 1999-02-08 | B cell inhibitors |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR015514A1 (en) |
AU (1) | AU2832399A (en) |
CO (1) | CO4980854A1 (en) |
PE (1) | PE20000281A1 (en) |
WO (1) | WO1999041239A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002012189A1 (en) * | 2000-08-09 | 2002-02-14 | Mitsubishi Pharma Corporation | Fused bicyclic amide compounds and medicinal use thereof |
IL156315A0 (en) * | 2000-12-07 | 2004-01-04 | Cv Therapeutics Inc | Abca-1 elevating compounds |
WO2002072549A1 (en) * | 2001-03-12 | 2002-09-19 | Millennium Pharmaceuticals, Inc. | Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
ATE316085T1 (en) | 2001-08-15 | 2006-02-15 | Du Pont | ARYL AMIDES SUBSTITUTED WITH HETEROCYCLES ORTHO TO CONTROL INVERTEBRATE PESTS |
EP1503986B1 (en) * | 2001-12-21 | 2015-09-30 | Cytokinetics, Inc. | Compositions and methods for treating heart failure |
US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
US8686048B2 (en) | 2010-05-06 | 2014-04-01 | Rhizen Pharmaceuticals Sa | Immunomodulator and anti-inflammatory compounds |
EP2594555B1 (en) * | 2010-07-02 | 2018-03-07 | ASKA Pharmaceutical Co., Ltd. | HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
WO2012109329A2 (en) | 2011-02-08 | 2012-08-16 | Children's Medical Center Corporation | Methods for treatment of melanoma |
US9499484B2 (en) * | 2012-04-02 | 2016-11-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Indole, indoline derivatives, compositions comprising them and uses thereof |
PL3060563T3 (en) | 2013-10-25 | 2018-10-31 | Novartis Ag | Ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors |
ES2756748T3 (en) | 2014-10-03 | 2020-04-27 | Novartis Ag | Use of fused ring bicyclic pyridyl derivatives as fgfr4 inhibitors |
US9802917B2 (en) | 2015-03-25 | 2017-10-31 | Novartis Ag | Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide |
US10730839B2 (en) * | 2016-11-27 | 2020-08-04 | Russell Dahl | Quinolines as cytoprotective agents |
CN111164075A (en) * | 2017-09-20 | 2020-05-15 | 北京加科思新药研发有限公司 | Fused ring derivatives useful as FGFR4 inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1305458A (en) * | 1969-02-26 | 1973-01-31 | ||
US3699123A (en) * | 1970-03-24 | 1972-10-17 | Sandoz Ltd | 4-(3-amino-2-hydroxy-propoxy) indole derivatives |
FR2121394A1 (en) * | 1971-01-08 | 1972-08-25 | Anvar | 2-methyl indole 3-carboxylic acid amides - antiinflammatories analgesics, tranquillisers, fungicides, herbicides and inters |
US5484944A (en) * | 1993-10-27 | 1996-01-16 | Neurogen Corporation | Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands |
-
1999
- 1999-02-08 AR ARP990100525A patent/AR015514A1/en unknown
- 1999-02-08 AU AU28323/99A patent/AU2832399A/en not_active Abandoned
- 1999-02-08 WO PCT/EP1999/000817 patent/WO1999041239A1/en active Application Filing
- 1999-02-08 CO CO99007017A patent/CO4980854A1/en unknown
- 1999-02-09 PE PE1999000110A patent/PE20000281A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO4980854A1 (en) | 2000-11-27 |
WO1999041239A1 (en) | 1999-08-19 |
AR015514A1 (en) | 2001-05-02 |
PE20000281A1 (en) | 2000-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3485999A (en) | Neo-tryptophan | |
AU5170900A (en) | Cell proliferation inhibitors | |
AU5991699A (en) | Quinolizinones as integrin inhibitors | |
AU2548699A (en) | Cell death inhibitors | |
AU9392998A (en) | Pack-a-pillow | |
AU5185899A (en) | Pack | |
AU9059798A (en) | Urokinase inhibitors | |
AU2832399A (en) | B cell inhibitors | |
AU4685799A (en) | Telomerase inhibitors | |
AU3437799A (en) | City-car | |
AU3522399A (en) | Carvedilol-galenics | |
AU5185799A (en) | Pack | |
AU3235100A (en) | Prothease inhibitors | |
AU5407599A (en) | Sphingolipid-desaturase | |
AU3253699A (en) | Myxochelines | |
AU8363398A (en) | Capotasto | |
AU2609599A (en) | Sensor-coupling | |
AU1057000A (en) | Carrying aid | |
AU3204999A (en) | Futureball | |
AU2069199A (en) | Codelets | |
AU5223199A (en) | Bathtub-bathseat | |
AU1055399A (en) | Rollerboard | |
EP0953510A3 (en) | Case | |
AU6020599A (en) | Cell surface immunomodulators | |
AU9347498A (en) | Imidazotriazolopyrimidines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |